Fundz

GentiBio Appoints Mark Bach, M.D., Ph.D. as Chief Medical Officer

PRIVATESep 30, 2024

Position

Chief Medical Officer

Company

GentiBio

Mark Bach
mark.bach@gentibio.com
CambridgeBiotechnologyHealth CareTherapeutics

Description

GentiBio announced the appointment of Mark Bach, M.D., Ph.D. as Chief Medical Officer

Quick answer

GentiBio Appoints Mark Bach, M.D., Ph.D. as Chief Medical Officer (September 30, 2024). GentiBio is based in Cambridge, Massachusetts, United States.

Who is the new Chief Medical Officer at GentiBio?
GentiBio named Mark Bach Chief Medical Officer, announced September 30, 2024.
What did GentiBio announce on September 30, 2024?
GentiBio announced the appointment of Mark Bach, M.D., Ph.D. as Chief Medical Officer
What does GentiBio do?
GentiBio is a leading cell and gene therapy company specializing in engineered regulatory T cells (Tregs) programmed to treat autoimmune and inflammatory diseases.
Where is GentiBio based?
GentiBio is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Tagworks Pharmaceuticals (October 1, 2024), Prothena Corporation (September 27, 2024), Century Therapeutics (September 27, 2024) and Aethlon Medical (October 3, 2024) also announced leadership changes within 45 days of GentiBio.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at GentiBio, and when

A new leader at GentiBio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day GentiBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GentiBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GentiBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GentiBio

Location

Cambridge, Massachusetts, United States

About

GentiBio is a leading cell and gene therapy company specializing in engineered regulatory T cells (Tregs) programmed to treat autoimmune and inflammatory diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GentiBio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Tom
Likely contact at this company
••••••••@••••••••

See Tom's verified email →

Mark
Likely contact at this company
••••••••@••••••••

See Mark's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for GentiBio's next move

Learn about Strategic plan

GentiBio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.